Headquartered in Rovereto sul Secchia near Modena, Lameplex manufactures plastic single/multi-dose containers for pharmaceutical, diagnostic, medical device, veterinary and cosmetic applications, with an emphasis on ophthalmic, vaccine, vaginal and rectal applications. Lameplast also does injection molding, blow molding and injection blow molding, enabling it to produce custom packaging solutions for demanding applications.
Lameplast brings Tekni-Plex specific expertise in unit and multi-dose packaging that was not part of its portfolio, according to Tekni-Plex president and CEO Paul Young.
“We continue to drive our strategy by growing our business organically and through mergers and acquisitions,” Young said in a news release. “We have specifically focused on expanding our healthcare packaging offerings, with M&A in product or technology adjacencies. We will now be able to offer a rigid packaging solution for prescription and over-the-counter medications and vaccines, in addition to our Tekni-Films flexible packaging options.”
Lameplast’s quality management system is ISO 15378 and ISO 9001 certified. The company also holds the CE mark holder for Class I medical devices. Production is carried out in Class ISO 7 (Class 10,000) and ISO 8 (Class 100,000) controlled contamination environments according to ISO 14644-1.
Lameplast general manager Luca Iulli will continue to oversee the operation, which adds approximately 130 employees to the more than 3,000-person global Tekni-Plex team.
Lameplast is the twelfth acquisition that Wayne, Pa.-based Tekni-Plex has made in the past five years.